Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43487,1774,1.01 [0.92-1.10],0.8555039962227831
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,42781,424,1.14 [0.95-1.35],0.1541354493050906
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,47517,322,0.99 [0.81-1.22],0.9492125668240812
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,32867,1547,1.09 [0.99-1.20],0.0760253993126825
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47409,214,0.95 [0.73-1.22],0.6698371638530296
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,44329,171,1.18 [0.90-1.54],0.2310693673865725
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",49855,212,0.95 [0.74-1.23],0.6976612090659526
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,49861,143,0.83 [0.60-1.14],0.2408188057590217
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43310,116,1.32 [0.96-1.81],0.087802747790471
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,48232,231,1.06 [0.83-1.34],0.6499873781928991
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,48153,152,1.09 [0.82-1.46],0.5617413655395599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50020,131,1.15 [0.85-1.57],0.3662162084988662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50008,161,0.93 [0.70-1.25],0.6313649059067233
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",49996,149,0.96 [0.71-1.29],0.781104506194155
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,49335,103,1.04 [0.73-1.48],0.8345497700889581
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",47626,815,1.07 [0.94-1.21],0.2955781748811321
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47091,280,1.21 [0.99-1.49],0.0665740951571124
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,47369,558,1.01 [0.87-1.18],0.8616478359126338
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",40119,130,0.94 [0.67-1.30],0.6939934716810952
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40101,112,0.85 [0.59-1.22],0.3858609976387287
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",40501,512,0.93 [0.79-1.10],0.4256501067725105
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",40518,529,0.94 [0.80-1.11],0.4688531385033636
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22698,655,1.01 [0.88-1.17],0.8572091616303108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18178,232,0.91 [0.71-1.17],0.4751452016821182
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40092,103,1.08 [0.75-1.54],0.6847937761477556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,44673,1549,1.16 [1.05-1.27],0.0021316897258154
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",47510,654,0.97 [0.84-1.12],0.6486134985486229
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,49115,229,0.92 [0.72-1.17],0.49372124771899
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50173,219,0.93 [0.72-1.19],0.5629401754147553
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,49630,129,1.27 [0.94-1.71],0.120738135349324
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50186,130,1.20 [0.88-1.62],0.2497872902106523
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Stomach,50278,98,1.21 [0.85-1.71],0.2931107481191606
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,49738,579,0.97 [0.83-1.13],0.7162925754523799
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50190,212,0.98 [0.76-1.26],0.8878091035878114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50198,178,0.87 [0.66-1.15],0.3170800475042193
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50082,101,0.88 [0.61-1.27],0.4855520260808479
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",50086,100,0.92 [0.63-1.33],0.6480371489269743
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,49919,384,1.08 [0.90-1.30],0.4075731081130118
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,50215,170,1.18 [0.91-1.54],0.2160196073841767
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,50019,361,0.88 [0.72-1.07],0.1874350423572877
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of breast,27059,138,0.83 [0.60-1.15],0.2596666596009328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Leiomyoma of uterus,26565,980,0.95 [0.84-1.07],0.3806598159373718
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,47724,383,1.21 [1.01-1.44],0.0372259784924209
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,47100,695,1.14 [1.00-1.31],0.0551171408838129
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,47100,695,1.14 [1.00-1.31],0.0551171408838129
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43385,902,1.17 [1.04-1.32],0.0076647521460984
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49222,136,0.76 [0.55-1.05],0.1010577580216409
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,49684,166,1.30 [1.00-1.69],0.0502093279295599
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,40598,2314,1.12 [1.04-1.22],0.0038867364895545
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,47283,1061,1.09 [0.97-1.22],0.1422675036503673
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,45765,270,1.13 [0.91-1.40],0.2597810886155623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,47968,217,0.94 [0.73-1.21],0.6332433924370997
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45737,242,1.13 [0.90-1.42],0.2924515319172047
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,46578,1083,1.10 [0.98-1.23],0.1050344506052354
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,46544,1049,1.10 [0.98-1.23],0.1136626275308013
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,46516,361,0.91 [0.73-1.13],0.4024585729502861
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",46521,359,0.92 [0.74-1.15],0.4665900419156972
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40255,1971,1.12 [1.02-1.22],0.012090441374565
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",38547,263,1.10 [0.88-1.38],0.4153426287638468
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,40100,1816,1.12 [1.03-1.23],0.0114472849235686
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,38382,98,1.43 [1.02-2.00],0.0377291254933431
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",38453,169,1.21 [0.92-1.58],0.1721543370703678
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,42501,1281,1.11 [1.00-1.23],0.0517753044423498
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",41668,448,1.04 [0.88-1.25],0.633328689298787
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49489,333,0.94 [0.77-1.16],0.5766462516964769
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",49615,241,0.98 [0.77-1.25],0.8928914350903475
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,46796,114,0.89 [0.63-1.26],0.5134696451991352
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",50087,114,0.86 [0.61-1.23],0.4144011857622905
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",41334,114,0.89 [0.63-1.26],0.5176489679874161
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Alcohol dependence,46818,136,0.84 [0.61-1.16],0.2900728411326583
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,46706,115,1.45 [1.07-1.98],0.0178721143413911
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41326,106,0.87 [0.61-1.26],0.4686030910082223
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",41859,639,1.11 [0.96-1.28],0.1435421715141218
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression,47148,559,1.09 [0.94-1.27],0.2513736452844139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression or dysthymia,41354,484,1.15 [0.98-1.35],0.0957280589755017
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",41467,247,1.10 [0.88-1.39],0.3902346129577471
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Other anxiety disorders,47420,129,1.02 [0.74-1.41],0.9019631737048756
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,42982,2888,1.10 [1.02-1.18],0.0083792175349722
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,39010,257,1.10 [0.88-1.38],0.384576439833013
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,49987,204,1.13 [0.89-1.45],0.315092144550104
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,47655,947,1.07 [0.95-1.20],0.2547191832706132
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,47002,294,1.02 [0.82-1.26],0.861793129276112
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,46866,158,1.11 [0.83-1.47],0.485747707891053
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",49683,144,1.09 [0.81-1.47],0.5690644150571886
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48643,155,1.02 [0.76-1.36],0.9027717818445076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,47038,330,1.17 [0.96-1.42],0.118970855580523
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,49151,251,1.12 [0.89-1.41],0.3185885179490777
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48003,1313,1.12 [1.01-1.24],0.0276412555264703
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",46926,236,1.22 [0.97-1.53],0.0843076211211722
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47447,757,1.07 [0.94-1.22],0.3038273089605714
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,49684,161,0.89 [0.66-1.19],0.4193592669139061
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,49634,111,0.87 [0.61-1.24],0.4332802528872075
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,49303,233,1.00 [0.79-1.26],0.975220691521548
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",48973,721,0.97 [0.85-1.12],0.6858576060641779
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,48669,417,1.01 [0.84-1.21],0.9186441736662548
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48399,147,0.79 [0.57-1.07],0.1304728186151785
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48486,234,1.01 [0.80-1.29],0.9040548585891044
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48404,152,1.25 [0.94-1.65],0.1238304333750414
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,43287,315,1.17 [0.95-1.42],0.1323610685241155
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,43752,780,1.11 [0.98-1.26],0.1142445284735115
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,48286,425,1.26 [1.07-1.49],0.0065141666248731
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49613,105,1.52 [1.11-2.08],0.008397278849638
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4260,105,1.41 [1.01-1.98],0.0464195934056362
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",45458,105,1.54 [1.13-2.10],0.0065782602181188
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,48939,183,1.01 [0.77-1.32],0.9318222581882982
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,48857,101,1.22 [0.87-1.73],0.2462874643408229
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",48914,170,1.22 [0.93-1.58],0.1464886002454987
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49194,193,0.83 [0.64-1.09],0.1893760229341337
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,50068,261,1.16 [0.93-1.44],0.187551364535968
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,48570,204,1.18 [0.93-1.51],0.1750099505850213
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,35612,6434,1.05 [1.00-1.12],0.0596657721532945
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,49023,134,0.87 [0.63-1.20],0.3859378750930693
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",37469,4445,1.08 [1.02-1.15],0.0112397736199437
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,37535,4511,1.09 [1.02-1.16],0.009452311560752
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33180,156,1.23 [0.93-1.63],0.150441863125364
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",45959,2358,1.00 [0.93-1.09],0.9438664926637396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,45017,1416,0.97 [0.88-1.08],0.6077921012191844
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48211,473,1.00 [0.84-1.18],0.9907451086721196
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,48675,937,1.00 [0.88-1.13],0.9901265318168408
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50015,184,0.95 [0.72-1.25],0.701396021296909
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44180,579,0.99 [0.84-1.15],0.8549130937002651
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,45442,1874,1.01 [0.92-1.10],0.8641653166280495
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,48649,214,1.23 [0.97-1.56],0.08247335068288
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,48854,452,1.09 [0.92-1.29],0.3409166612933308
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,48612,177,0.90 [0.68-1.19],0.4460982037832034
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,48614,179,0.90 [0.68-1.19],0.4726851085379984
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33195,171,0.93 [0.70-1.23],0.6021938284324058
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41678,117,1.51 [1.11-2.04],0.0080691755803501
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,41805,244,0.86 [0.67-1.10],0.2206083113465751
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,27725,230,0.93 [0.73-1.19],0.5811575775099758
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,28356,861,0.88 [0.77-1.00],0.0571832880682486
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,41694,133,0.95 [0.69-1.31],0.7542650819979033
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,41741,180,0.73 [0.55-0.98],0.0338515657345939
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",48174,407,1.07 [0.89-1.28],0.475470451863809
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",48491,308,1.21 [0.99-1.47],0.0639979193455033
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",48557,259,1.24 [1.00-1.54],0.0471573083033298
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",48716,228,1.30 [1.04-1.63],0.0214186950941779
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,47962,153,0.94 [0.70-1.27],0.6925432837488166
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48060,251,0.99 [0.79-1.25],0.962731354333644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47377,279,1.06 [0.86-1.32],0.572996082497027
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47336,238,1.11 [0.88-1.40],0.3728007114110452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",49834,228,1.16 [0.92-1.46],0.22058085636619
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,48029,931,0.85 [0.75-0.96],0.0104261197138114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,47899,173,0.95 [0.71-1.25],0.6948427222566491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40088,4012,1.08 [1.01-1.14],0.0151693376889216
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,49900,211,1.17 [0.92-1.49],0.2010449208995179
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,46597,440,1.11 [0.93-1.31],0.2367252787383388
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",46542,385,1.09 [0.91-1.31],0.3679211211348785
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,48445,492,1.08 [0.92-1.27],0.3445494987915325
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,48434,481,1.08 [0.92-1.28],0.3438931477806153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,48688,1197,0.96 [0.87-1.07],0.5081361628702019
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,47675,184,0.99 [0.76-1.30],0.9564214429085792
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,47738,247,1.07 [0.86-1.35],0.539661503582991
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48256,765,0.94 [0.83-1.08],0.3982480285459077
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,47845,354,0.89 [0.73-1.08],0.247339991461022
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23112,125,0.84 [0.60-1.18],0.3034258107334376
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,44922,1959,1.08 [1.00-1.18],0.0571386997455639
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,47949,342,1.04 [0.85-1.27],0.707109915365987
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",47999,392,1.04 [0.87-1.26],0.6597411272392122
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",47999,392,1.04 [0.87-1.26],0.6597411272392122
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",46903,1620,1.08 [0.99-1.18],0.1015938255558339
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Asthma,35884,1620,1.11 [1.01-1.21],0.0317162716916794
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",35362,1620,1.10 [1.01-1.21],0.0356758902070563
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",35860,1596,1.09 [1.00-1.20],0.0616847823815246
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,49544,176,1.14 [0.87-1.48],0.3485363627940248
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,47390,135,1.18 [0.87-1.59],0.2871842187081583
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",49698,135,1.18 [0.87-1.60],0.2798645625286845
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47376,121,1.10 [0.80-1.52],0.5622008851073683
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,46213,217,1.01 [0.79-1.30],0.9116900901119414
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,46460,464,1.02 [0.86-1.21],0.7867904616762832
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,47792,211,1.09 [0.85-1.39],0.501075707743035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34193,11370,1.04 [1.00-1.09],0.0604114112510606
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49249,814,1.02 [0.90-1.16],0.7741480666671953
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50206,181,1.01 [0.78-1.33],0.916374947345499
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,50214,168,1.07 [0.81-1.41],0.6356545841774238
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,48645,210,1.12 [0.88-1.43],0.3436511361316039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48630,195,1.05 [0.82-1.36],0.6852302449483437
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50189,200,1.01 [0.78-1.31],0.926850336958176
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48622,187,0.97 [0.75-1.27],0.8455398014782409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48104,154,1.25 [0.95-1.65],0.1085653129805988
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50047,103,1.11 [0.79-1.57],0.5455320156528911
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38229,535,1.01 [0.86-1.18],0.8859797807050436
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",41926,4232,1.00 [0.95-1.07],0.8772432035747807
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,38357,663,1.09 [0.95-1.25],0.2320227977218598
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,39050,1356,0.96 [0.87-1.07],0.4744144778131896
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,37844,150,1.07 [0.80-1.43],0.6465257838161187
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38093,399,1.07 [0.89-1.28],0.4935012596174596
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,37809,115,0.86 [0.61-1.23],0.4146816045087381
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,37995,301,0.83 [0.67-1.03],0.0960170421391335
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,37936,242,1.31 [1.06-1.63],0.0142944785875796
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50000,168,1.35 [1.04-1.75],0.0243358103771556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,37938,244,0.87 [0.68-1.10],0.2433018938271924
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),39288,1594,0.98 [0.90-1.08],0.7328842644222529
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,49955,246,1.06 [0.85-1.34],0.588878401829054
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,38553,859,0.99 [0.87-1.12],0.8154936822534644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,38028,334,0.87 [0.71-1.07],0.180273324696691
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,49950,304,0.94 [0.76-1.16],0.5384886920502117
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,49909,200,1.02 [0.79-1.31],0.9048512526674763
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,44010,3169,1.06 [0.99-1.13],0.100385256475732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,42000,1159,1.02 [0.92-1.14],0.7006637016853227
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,41088,247,1.16 [0.93-1.45],0.1856938031317915
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,41043,202,1.07 [0.83-1.38],0.5854055121592714
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,42524,1683,1.08 [0.98-1.18],0.1089203674562751
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48360,1485,1.05 [0.95-1.15],0.3284010534216067
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,39318,3919,1.01 [0.95-1.08],0.6758222232690263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49599,113,1.02 [0.73-1.43],0.909468577866424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",50130,157,0.99 [0.74-1.32],0.9414308559886506
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,47032,157,1.00 [0.74-1.33],0.9744405713692053
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,46993,118,0.89 [0.63-1.25],0.487191272587456
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",50005,274,0.92 [0.74-1.15],0.4591542522322379
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,47149,274,0.92 [0.74-1.16],0.4883112729772642
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47121,246,0.92 [0.73-1.17],0.505570785390763
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48079,1204,1.09 [0.98-1.21],0.1020252318940801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48065,1190,1.09 [0.98-1.21],0.1106304621661164
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,35590,191,1.15 [0.89-1.49],0.2751062455785706
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal stricture,49358,191,1.16 [0.90-1.49],0.2629243450369768
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",35525,126,1.15 [0.84-1.58],0.3674704165781798
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36578,1179,0.98 [0.88-1.09],0.7056234485330304
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,35723,324,1.01 [0.83-1.24],0.904729723879272
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,35960,561,1.14 [0.98-1.33],0.0816999118628217
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,47052,502,1.13 [0.97-1.33],0.1246795720846035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,49390,176,1.10 [0.84-1.43],0.5057065490130679
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35678,279,0.95 [0.76-1.19],0.6630005232498994
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35534,135,1.06 [0.78-1.44],0.710258095012503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,37130,1731,1.02 [0.93-1.11],0.7341761045667288
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,35929,530,0.92 [0.78-1.08],0.3162286358318873
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,49362,148,1.05 [0.79-1.41],0.7265138226386723
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,48675,241,0.84 [0.65-1.07],0.1485647615974261
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,48570,136,0.84 [0.60-1.15],0.2763953583244207
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",47605,1224,1.10 [0.99-1.22],0.0710230305194471
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,47370,989,1.11 [0.99-1.25],0.0667145011815332
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,46574,193,1.33 [1.04-1.69],0.022045357351311
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46481,100,1.34 [0.96-1.88],0.0847549287971779
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,46509,128,1.05 [0.76-1.45],0.7502681041936623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),49933,128,1.04 [0.76-1.44],0.79471768535743
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,47555,604,1.10 [0.95-1.28],0.1866258099706881
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47086,135,1.24 [0.92-1.67],0.1516427023679511
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,47062,111,1.22 [0.88-1.69],0.2296719713692819
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47047,96,1.08 [0.75-1.55],0.6823710670034521
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,47336,385,1.07 [0.89-1.29],0.468000560128091
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,47322,371,1.05 [0.87-1.27],0.598144374364131
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,44073,3049,0.96 [0.90-1.03],0.2918461126421581
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,49372,203,0.93 [0.71-1.20],0.5630155472811017
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49442,893,0.99 [0.88-1.12],0.8865001364478042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,47136,1137,0.99 [0.89-1.10],0.8206692241652969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,48481,774,0.92 [0.80-1.05],0.2176460530232458
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",47882,175,0.86 [0.64-1.14],0.2818310889437826
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,48202,495,0.93 [0.79-1.10],0.4035153933967599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,49717,176,0.92 [0.69-1.21],0.5436769438480724
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,49678,137,0.95 [0.69-1.30],0.7282033771469115
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49644,103,0.95 [0.66-1.36],0.7761863507464424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,49681,109,0.85 [0.60-1.22],0.3861167801532219
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,49676,104,0.86 [0.60-1.24],0.430281006977421
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48661,112,1.08 [0.78-1.52],0.636119288003776
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49260,711,0.98 [0.86-1.13],0.8162169558569374
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46180,181,0.75 [0.57-1.00],0.0526132944063309
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46197,198,0.81 [0.62-1.07],0.1352754731808969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46150,151,0.83 [0.61-1.13],0.2479557469013785
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46431,432,1.08 [0.91-1.28],0.4097701697243726
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46383,384,1.02 [0.85-1.23],0.8127720285938722
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36190,7780,1.05 [1.00-1.10],0.053364100788226
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39343,4513,1.04 [0.98-1.10],0.1684267675375279
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,45296,2372,1.08 [1.00-1.17],0.0392965792241648
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35129,299,1.23 [1.01-1.51],0.0390345359762433
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35735,905,1.09 [0.96-1.22],0.1839764779635423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",49434,287,1.26 [1.03-1.55],0.0243262019985095
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,49454,259,1.34 [1.09-1.66],0.005949939588429
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37076,2246,1.04 [0.96-1.13],0.3662663369125341
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",42098,2246,1.03 [0.95-1.12],0.4714709497810299
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,34963,133,0.95 [0.69-1.31],0.7443593234732484
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",49140,129,0.96 [0.69-1.33],0.7938035450344486
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,35259,429,1.06 [0.89-1.26],0.4962214709997752
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,34969,139,0.88 [0.64-1.20],0.4078929451982089
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,35381,551,1.07 [0.92-1.25],0.3652115874831719
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",49945,271,1.16 [0.93-1.43],0.1804012411846087
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,35864,1034,1.04 [0.93-1.17],0.4566564869017196
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35605,775,0.97 [0.85-1.11],0.6708268996612334
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,37336,2506,1.03 [0.95-1.11],0.4953019285538879
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),34957,127,1.01 [0.73-1.39],0.9468771042591684
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35290,460,0.99 [0.83-1.17],0.8963292150692961
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,34939,109,1.13 [0.81-1.58],0.4661836408674503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),34947,117,1.13 [0.82-1.57],0.4427587761653332
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,35769,939,1.01 [0.90-1.14],0.8739846308772447
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35640,810,1.05 [0.92-1.19],0.4623496987069624
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,38907,548,1.03 [0.88-1.20],0.7080658576607333
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49186,251,1.03 [0.82-1.30],0.8062415147710861
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49044,109,1.19 [0.86-1.67],0.2978787904666559
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,43442,126,1.06 [0.77-1.46],0.7376782775179669
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,43889,573,0.99 [0.84-1.15],0.8559231720279175
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,45126,1810,0.98 [0.90-1.07],0.6964280045735314
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,43682,366,1.03 [0.85-1.24],0.7731292878998203
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,43482,166,0.96 [0.72-1.28],0.7714830824774189
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",44746,1430,1.01 [0.91-1.11],0.9034932892842557
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43416,100,1.09 [0.76-1.55],0.6472689891050833
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,43771,455,1.08 [0.91-1.28],0.3560702096063596
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43509,193,1.07 [0.83-1.39],0.5884289846406153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43469,153,0.81 [0.59-1.09],0.1671251550820781
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,43590,274,0.95 [0.76-1.19],0.6640717372170515
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43440,124,1.11 [0.81-1.53],0.5147020630050596
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,43917,601,1.08 [0.94-1.25],0.2860251577820407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,43540,616,1.15 [1.00-1.33],0.0495129521079969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43058,134,1.16 [0.86-1.58],0.3269448297065123
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43095,171,1.06 [0.80-1.39],0.6922389656618755
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43127,203,1.32 [1.04-1.67],0.0231848198216751
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43020,96,1.30 [0.92-1.84],0.1313123624492443
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43148,224,1.20 [0.95-1.51],0.123905580021491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43123,199,1.10 [0.86-1.42],0.4461501327070972
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,43441,517,1.05 [0.89-1.23],0.5718760238300251
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43031,107,0.84 [0.58-1.20],0.3341685101254046
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43079,155,1.00 [0.75-1.35],0.9757049102696502
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43171,247,1.02 [0.81-1.28],0.8959927181851318
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43044,120,0.69 [0.48-0.98],0.0405536258634356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",43799,875,1.00 [0.89-1.14],0.9438553487554638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,43258,334,0.99 [0.81-1.21],0.9303953799136944
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,43390,466,0.99 [0.83-1.17],0.892638280813277
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,46556,335,1.04 [0.85-1.27],0.6977121572265745
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,46986,765,1.04 [0.91-1.19],0.5653640950634735
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46317,96,1.07 [0.74-1.54],0.7300486964340918
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46337,116,1.04 [0.75-1.45],0.811130464017744
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46423,202,0.94 [0.73-1.22],0.6558280051552117
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,39858,8333,0.98 [0.94-1.03],0.4078664690932732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19935,1257,1.01 [0.91-1.12],0.8628320418471658
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,45122,499,1.17 [1.00-1.37],0.0501022897115559
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,44758,135,1.07 [0.78-1.46],0.6731454791008011
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,45317,107,1.57 [1.16-2.13],0.0032214251935612
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,45347,137,1.17 [0.87-1.59],0.3010286131938017
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45343,133,1.13 [0.83-1.54],0.4374985581074163
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49547,480,1.04 [0.88-1.23],0.6315333547832774
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,49378,140,1.25 [0.93-1.67],0.1336416664614689
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49415,348,1.06 [0.88-1.29],0.5263783442957932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49232,165,1.08 [0.82-1.42],0.5908386877026692
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,45898,2038,1.05 [0.96-1.13],0.2894419687645202
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,44044,184,0.97 [0.74-1.27],0.802002928878535
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44021,161,1.18 [0.90-1.56],0.2353606036714792
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,44394,534,1.16 [1.00-1.36],0.0514933522067291
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44082,222,0.99 [0.77-1.27],0.9376470114033978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,45184,1324,1.04 [0.94-1.15],0.4043064197459141
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19231,553,1.08 [0.92-1.27],0.3267131804509517
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18782,104,1.06 [0.75-1.51],0.7275520201678571
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydrocele,18777,99,0.99 [0.69-1.43],0.9741213992501594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18842,164,1.14 [0.87-1.51],0.3373626520719645
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18839,161,1.05 [0.79-1.40],0.7252745216246734
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18891,213,0.72 [0.55-0.94],0.0147201933271969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26800,473,0.95 [0.81-1.13],0.5903770078599306
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26474,147,0.94 [0.70-1.28],0.6967144541196799
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26495,168,0.97 [0.73-1.29],0.8311999456856134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26438,111,0.97 [0.69-1.37],0.8725658422630485
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26746,542,1.00 [0.86-1.17],0.9685602718171384
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26334,130,0.81 [0.58-1.12],0.2014988731704564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26445,241,1.05 [0.83-1.33],0.6770353562328093
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24702,4510,0.95 [0.90-1.01],0.1357069105799347
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Endometriosis,20551,359,1.12 [0.92-1.36],0.250900848813459
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20288,96,1.21 [0.84-1.74],0.3021433617922117
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20356,164,1.15 [0.87-1.52],0.3112314786327681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,20970,778,1.04 [0.91-1.18],0.5867505259919141
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20600,408,0.96 [0.80-1.16],0.6816475028761466
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21128,936,0.89 [0.78-1.00],0.056012769830082
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20502,310,0.80 [0.65-1.00],0.0491277359778559
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20628,436,0.96 [0.80-1.14],0.6163500826362454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20287,95,1.02 [0.70-1.49],0.913935730370358
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20376,184,1.07 [0.82-1.41],0.600977561326878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27076,260,1.13 [0.90-1.41],0.289601165226439
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27086,246,1.15 [0.92-1.45],0.2157634021350086
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27111,137,1.27 [0.94-1.71],0.1186121674051882
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27102,151,1.24 [0.93-1.65],0.138410771764966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20336,144,0.96 [0.71-1.31],0.8008853845287903
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20305,113,0.77 [0.53-1.10],0.1535102696705495
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20332,140,1.17 [0.87-1.58],0.3034848815084736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Irregular menses,27007,463,1.14 [0.97-1.34],0.1235081815681027
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21511,1319,1.01 [0.91-1.12],0.8155044416916658
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21050,858,0.95 [0.84-1.08],0.4588880709408497
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27092,194,1.02 [0.79-1.32],0.8772716559661354
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20652,460,0.83 [0.69-0.99],0.0396034662256191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20519,327,0.93 [0.75-1.14],0.4752058106179806
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21074,882,0.90 [0.79-1.02],0.0922792612243577
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female infertility,20307,115,1.10 [0.78-1.55],0.6008954717549503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20300,108,1.08 [0.75-1.54],0.6791415310519786
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27107,863,0.85 [0.74-0.98],0.0267549874232982
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27112,1171,0.85 [0.75-0.96],0.0097506129904432
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27108,463,1.02 [0.85-1.22],0.8588780835547889
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26776,131,0.91 [0.65-1.27],0.5742263136564725
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26834,189,0.86 [0.65-1.14],0.2968528681491452
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26800,155,1.25 [0.94-1.68],0.1276111315105502
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27127,165,0.66 [0.48-0.90],0.0087533627033278
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27129,162,0.65 [0.47-0.89],0.0065242503043292
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27124,406,0.76 [0.62-0.93],0.0082913656627812
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26837,119,0.49 [0.33-0.72],0.0002349266551741
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,26945,227,0.82 [0.63-1.06],0.1279605199495463
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26389,145,0.95 [0.69-1.31],0.7610727617301687
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26440,196,0.78 [0.59-1.04],0.0932324943869245
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26492,248,0.84 [0.65-1.08],0.1725866787737019
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26388,144,0.89 [0.64-1.23],0.4656226895309893
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26379,135,0.91 [0.65-1.27],0.5850959272599465
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26393,149,0.67 [0.48-0.93],0.0177804745342226
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26168,227,0.82 [0.63-1.07],0.148497844613317
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26364,423,0.78 [0.64-0.95],0.0151169654638935
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26591,650,0.83 [0.71-0.98],0.0296468162261088
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27129,165,1.01 [0.75-1.36],0.9466753394922194
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25700,126,0.89 [0.63-1.26],0.5187620914206674
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26040,99,0.92 [0.63-1.36],0.6857103811721861
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27137,332,0.76 [0.61-0.95],0.0150447594331341
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27056,251,0.67 [0.52-0.87],0.0023844864651885
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27124,247,0.97 [0.76-1.24],0.7881527206947292
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27115,238,0.99 [0.77-1.27],0.9353221985234452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",49486,119,1.09 [0.79-1.51],0.6054720868699979
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,45266,1164,0.97 [0.87-1.08],0.6012734864570382
